Dna Content Quantification
Dna Content Quantification - Related Videos
09:16
Air-sampled Filter Analysis for Endotoxins and DNA Content
0 Views •
2016
Two complementary analyses of atmospheric biological particles from air sampled filters are described herein: the extraction and detection of endotoxin, and of DNA.
08:06
Genome-wide Determination of Mammalian Replication Timing by DNA Content Measurement
0 Views •
Cited by 6 •
2017
We describe here a relatively fast and simple approach for mapping genome-wide mammalian replication timing, from cell isolation to the basic analysis of the sequencing results. A genomic map of a representative replication program will be provided following the protocol.
13:32
High Content Screening in Neurodegenerative Diseases
0 Views •
Cited by 8 •
2012
We describe a methodology combining automated cell culturing with high-content imaging to visualize and quantify multiple cellular processes and structures, in a high-throughput manner. Such methods can aid in the further functional annotation of genomes as well as identify disease gene networks and potential drug targets.
15:28
A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
0 Views •
Cited by 30 •
2014
Here, we describe a phenotypic assay applicable to the High-throughput/High-content screens of small-interfering synthetic RNA (siRNA), chemical compound, and Mycobacterium tuberculosis mutant libraries. This method relies on the detection of fluorescently labeled Mycobacterium tuberculosis within fluorescently labeled host cell using automated confocal microscopy.
15:04
A Neuronal and Astrocyte Co-Culture Assay for High Content Analysis of Neurotoxicity
0 Views •
Cited by 46 •
2009
This article describes a novel protocol and reagent set designed for sensitive measurement of neurotoxic effects of compounds and treatments on co-cultures of neurons and astrocytes using high content analysis. Results demonstrate that high content analysis represents an exciting novel technology for neurotoxicity assessment.
FAQs
Fluorescence intensity provides the measurement scale: cells containing more DNA produce stronger dye-associated signal than cells containing less. When signals are plotted across many cells, groups corresponding to G0/G1, S, and G2/M emerge. This distribution connects DNA amount with cell-cycle organization, allowing researchers to examine proliferation patterns rather than a single bulk value.
Abnormal DNA content is important because it can indicate that a cell population does not follow the expected chromosome-copy pattern. In tumor samples, the measurement can therefore distinguish DNA-content abnormalities from more uniform populations and reveal heterogeneity. Comparing distributions helps investigators characterize how diverse the tumor cell population is.
Both approaches can provide DNA-content information, but the selected platform determines how the cellular signal is collected and organized for interpretation. Flow cytometry and image-based analysis therefore support the same broad measurement goal while fitting different experimental workflows. Researchers can select the approach that matches how they need to compare cellular populations.
A practical workflow begins by fixing the cells, treating them with a DNA-binding fluorescent dye, and analyzing the resulting signal by flow cytometry or an image-based method. Keeping these stages conceptually separate helps link preparation to measurement: fixation prepares the cellular sample, dye treatment creates the detectable signal, and analysis converts signal patterns into DNA-content information.
In anticancer-treatment studies, Dna Content Quantification enables comparisons between treated and untreated cell populations. Investigators can examine whether the distributions of cell-cycle states or abnormal DNA content change after treatment. These comparisons provide a way to assess treatment-associated effects on proliferation patterns and tumor-cell populations without reducing the response to a single measurement.
Within cancer research, the method connects several levels of tumor characterization. DNA-content patterns can be examined alongside chromosome copy number, ploidy, cell-cycle state, and heterogeneity, helping researchers describe tumor biology and disease progression. Its value is greatest when distributions are compared across samples or experimental conditions, rather than interpreted as an isolated signal.